serw-MX  [xml]  
 


    
 DeCS Categories

D04 Polycyclic Compounds .
D04.210 Fused-Ring Compounds .
D04.210.500 Steroids .
D04.210.500.668 Norsteroids .
D04.210.500.668.651 Norpregnanes .
D04.210.500.668.651.693 Norpregnenes .
D04.210.500.668.651.693.762 Norgestrel .
D04.210.500.668.651.693.762.450 Levonorgestrel .
D04.210.500.745 Pregnanes .
D04.210.500.745.745 Pregnenes .
D04.210.500.745.745.654 Pregnenediones .
D04.210.500.745.745.654.829 Progesterone .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.472 Hormones .
D06.472.334 Gonadal Hormones .
D06.472.334.734 Corpus Luteum Hormones .
D06.472.334.734.623 Progesterone .
D06.472.334.851 Gonadal Steroid Hormones .
D06.472.334.851.687 Progesterone Congeners .
D06.472.334.851.687.750 Progesterone .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.826 Receptors, Cytoplasmic and Nuclear .
D12.776.826.750 Receptors, Steroid .
D12.776.826.750.765 Receptors, Progesterone .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.472 Hormones .
D27.505.696.399.472.161 Androgens .
D27.505.696.399.472.277 Estrogens .
D27.505.696.399.472.858 Progestins .
SP8 Disasters .
SP8.946 Disaster Management .
SP8.946.234 Education in Disasters .
SP8.946.234.352 Public Awareness .
SP8.946.819 Prevention and Mitigation .
SP8.946.819.802 Social Communication .
SP8.946.819.802.768 Public Awareness .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Progestins .
Gestagen .
Gestagen Effect .
Gestagen Effects .
Gestagenic Agents .
Gestagenic Effect .
Gestagenic Effects .
Gestagens .
Progestagenic Agents .
Progestagens .
Progestational Agents .
Progestational Compounds .
Progestational Hormones .
Progestin .
Progestin Effect .
Progestin Effects .
Progestogen Effect .
Progestogen Effects .
Effect, Gestagen .
Effect, Gestagenic .
Effect, Progestin .
Effect, Progestogen .
Effects, Gestagen .
Effects, Gestagenic .
Effects, Progestin .
Effects, Progestogen .
Progestogens .
Progestational Hormones .
Progestational Hormone Analogs .
Progestin Analogs .
Progestational Hormones, Synthetic .
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. .
1.00
 
Progesterone .
Pregnenedione .
Progesterone, (13 alpha,17 alpha)-(+-)-Isomer .
Progesterone, (17 alpha)-Isomer .
Progesterone, (9 beta,10 alpha)-Isomer .
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. .
0.59
 
Progesterone Congeners .
Progestagens, Synthetic .
Progestational Hormone Analogs .
Progestational Hormone Analogues .
Progestational Hormones, Synthetic .
Progestin Analogs .
Progestin Analogues .
Progestins, Synthetic .
Progestogens, Synthetic .
Synthetic Progestational Hormones .
Synthetic Progestins .
Synthetic Progestagens .
Synthetic Progestogens .
Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities. .
0.50
 
Receptors, Progesterone .
Progesterone Receptor .
Receptor, Progesterone .
Progesterone Receptors .
Progestin Receptors .
Receptors, Progestin .
Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. .
0.49
 
Estrogens .
Estrogen .
Estrogen Effect .
Estrogen Effects .
Estrogen Receptor Agonists .
Estrogenic Agents .
Estrogenic Compounds .
Estrogenic Effect .
Estrogenic Effects .
Agents, Estrogenic .
Agonists, Estrogen Receptor .
Compounds, Estrogenic .
Effects, Estrogen .
Effects, Estrogenic .
Receptor Agonists, Estrogen .
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. .
0.43
 
Levonorgestrel .
Capronor .
Cerazet .
D-Norgestrel .
Microlut .
Microval .
Mirena .
NorLevo .
Norgeston .
Norplant .
Norplant-2 .
Plan B .
Vikela .
duofem .
D Norgestrel .
Norplant 2 .
Norplant2 .
l Norgestrel .
l-Norgestrel .
A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis. .
0.39
 
Androgens .
Androgen Effect .
Androgen Effects .
Androgen Receptor Agonists .
Androgenic Agents .
Androgenic Compounds .
Agents, Androgenic .
Agonists, Androgen Receptor .
Compounds, Androgenic .
Effect, Androgen .
Effects, Androgen .
Receptor Agonists, Androgen .
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. .
0.39
 
Norgestrel .
DL-Norgestrel .
Neogest .
Ovrette .
Postinor .
Wy-3707 .
DL Norgestrel .
Wy 3707 .
Wy3707 .
A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis. .
0.38
 
Public Awareness .
The process of informing the community as to the nature of the hazard and actions needed to save lives and property prior to and in the event of disaster (Material II - IDNDR, 1992) .
0.38